New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
On Jul. 29, 2024, a new project that aims to accelerate the development and accessibility of human avian…
Twist Bioscience Launched Synthetic RNA Control for H5N1 Influenza A
On Jul. 9, 2024, Twist Bioscience announced the expansion of its growing portfolio of synthetic viral controls with…
Moderna Received $176 million Award through BARDA to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
On Jul. 2, 2024, Moderna announced a project award of $176 million through the Rapid Response Partnership Vehicle…
Biotechnology | Influenza | Life Science News | Therapeutics | USDA | Vaccine | Veterinary
USDA Approved Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…
Moderna received U.S. FDA approval for RSV vaccine mRESVIA
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
Moderna announced contract with Brazil to supply 12.5 million COVID-19 vaccines as part of national vaccination campaign
On Apr. 22, 2024, Moderna announceda contract with the Ministry of Health in Brazil (Ministerio da Saude) to…
Biotechnology | CDC | COVID-19 | Vaccine
Novavax’s protein-based non-mRNA COVID-19 vaccine available as additional dose for individuals aged 65 and older
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory Committee on Immunization Practices…
COVID-19 vaccination and boosting during pregnancy protects infants for six months
On Feb. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) reported study results that showed…
Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia
On Jan. 31, 2024, researchers at the National Institutes of Health detected abnormal proteins in the spinal fluid…
NIH-supported researchers created single-cell atlas of the placenta during term labor
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
BioNTech aimed to start mRNA vaccine output in Rwanda in 2025
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
BioNTech and Australiaï¾’s State of Victoria signed agreement on strategic partnership to strengthen mRNA rcosystem
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
Japan’s MHLW approved CSL and Arcturus’s self-amplifying mRNA vaccine approved for COVID in adults
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) has granted full approval for Novavax’s…
FDA authorized updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variant
On Oct. 3, 2023, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the…
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
Pfizer and BioNTech received U.S. FDA approval for 2023-2024 COVID-19 vaccine
On Sept. 11, 2023, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) approved the…
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
COVID-19 vaccination and boosting during pregnancy benefits pregnant women and newborns
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
Masters of acclimation: Octopuses adjust to cold by editing their RNA
On Jul. 25, 2023, U.S. National Science Foundation-supported research, led by Joshua Rosenthal of the Marine Biological Laboratory…
Scientists recovered RNA expression profiles from extinct Tasmanian tiger
On Jul. 18, 2023, scientists reported that they had extracted, sequenced, and analyzed historical RNA from muscle and…
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
U.S. FDA approved treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
On Apr. 25, 2023, the U.S. FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS)…
Moderna finalized agreement with Government of the Republic of Kenya to establish an mRNA manufacturing facility
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
Texas A&M scientists disable protective gene In mosquitoes
On Mar. 15, 2023, scientists at Texas A&M announced that a research study: ﾓRNA interference is essential to…
Health Canada authorizeds Moderna’s Omicron-targeting bivalent COVID-19 vaccine in children & cdolescents
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the NIH announced that a new large-scale genetic analysis found a set of small…